%0 Journal Article
%T First donor haemovigilance system at a national level in China: Establishment and improvement.
%A Yang J
%A Fan D
%A Xie D
%A Guo X
%A Zhu W
%A He T
%A Huang X
%J Vox Sang
%V 118
%N 5
%D May 2023 9
%M 36896482
%F 2.996
%R 10.1111/vox.13421
%X <B>OBJECTIVE: </B>No systematic study has measured the incidence of adverse reactions (ARs) to blood donation at the national level in China before 2019. The objective of this study was to establish an effective reporting system to collect information on ARs to blood donation in China.<BR><B>METHODS: </B>The status of donor haemovigilance (DHV) in blood collection facilities in China was evaluated, and an online DHV system was established to collect data on ARs to blood donation in July 2019. The definitions of ARs were based on the International Society of Blood Transfusion (ISBT) standards. The prevalence and data quality of ARs from 2019 to 2021 were analysed.<BR><B>RESULTS: </B>A standard online reporting system has been established for ARs to blood donation. In total, 61, 62 and 81 participating sites were included in this pilot study in 2019, 2020 and 2021, respectively. From July 2019 to December 2021, 21,502 cases of whole-blood-related ARs and 1114 cases of apheresis platelet-related ARs were reported, with an incidence of 3.8‰ and 2.2‰, respectively. Data completeness for key reporting elements improved from 41.7% (15/36) in 2019 to 74.4% (29/39) in 2020. Data quality analysis for the year 2021 yielded similar results as for 2020.<BR><B>CONCLUSIONS: </B>The construction and continuous improvement of the blood donor safety monitoring system prompted the establishment of the DHV system. Improvements have been made to the DHV system in China, with a significant increase in sentinels and higher data quality.